Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$23.21 - $27.24 $3,551 - $4,167
-153 Reduced 45.13%
186 $4,000
Q1 2024

Apr 30, 2024

BUY
$26.4 - $32.56 $4,039 - $4,981
153 Added 82.26%
339 $9,000
Q1 2023

May 10, 2023

BUY
$25.31 - $29.02 $4,707 - $5,397
186 New
186 $5,000
Q4 2018

Feb 13, 2019

SELL
$27.94 - $44.61 $56,327 - $89,933
-2,016 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$38.6 - $46.12 $26,749 - $31,961
-693 Reduced 25.58%
2,016 $86,000
Q2 2018

Aug 16, 2018

SELL
$40.56 - $51.36 $1,297 - $1,643
-32 Reduced 1.17%
2,709 $112,000
Q1 2018

May 15, 2018

SELL
$53.61 - $67.26 $9,971 - $12,510
-186 Reduced 6.35%
2,741 $159,000
Q4 2017

Feb 08, 2018

BUY
$47.69 - $55.39 $139,588 - $162,126
2,927
2,927 $160,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.84B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.